As it looks to accelerate the pace of its AI development, Google is further streamlining the teams building its AI services, platforms, and tools. On Thursday, Logan Kilpatrick, who leads product ...

Google's AI firm DeepMind has used artificial intelligence to identify changes in human DNA that might cause diseases. The researchers believe they have pinpointed 89% of all the key mutations.

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Among the most important aspects of this story is AlphaFold, the artificial intelligence and foundation model platform developed by Google DeepMind and Isomorphic Labs, both Alphabet companies.

Since its founding in 2010, DeepMind has focused on building AI that might solve some of the world's stickiest problems, as varied as the climate crisis and protein folding. Last year, Google ...

Joining Suleyman – who co-founded DeepMind in 2010, sold the company to Google in 2014 and left Google in 2022 to co-found Inflection – is Karén Simonyan, Inflection AI co-founder and chief ...